The Di Bella method stemmed from the need to change approach to cancer prevention and treatment in consideration of the growing number of tumor cases which, alas, unequivocally demonstrate that modern preventive measures are still inadequate and insufficient.
Successful treatment options selected from among the best currently available result in a 29 per cent survival rate at 5 years according to the British Medical Journal (BMJ.COM).
Survival rate progressively diminishes after 5 years. These data clearly show that the approach to cancer treatment needs radically changing.

The Di Bella Method (MDB) suggests causal treatment, that is treatment aimed at eradicating the etiopathogenic (causal) factors of tumor onset, by restoring an upset biological terrain which allowed cancer to form. However, failure of chemotherapy to totally annihilate tumor cell populations allows most of residual tumor cells to resume proliferation and invasiveness in a less resistant biological terrain due to chemotherapy formerly received.
Moreover, tumor cells themselves tend to become less drug-sensitive and more drug-resistant after several chemotherapy cycles

By employing somatostatine, MDB treatment inhibits some of the most powerful tumor factors, like GH (main growth factor), IGF and many others.
Such action is further strengthened by the use of prolactin inhibitors.
The employment of retinoids helps bring tumor cells back to normality, i.e. differentiated cells. Combined with vitamin D, melatonin and vitamin E, they exert a synergic action with powerful antitumor and antioxidant effects, strengthening the immune system, inducing apoptosis (tumor cell planned death), and exerting antiproliferative, pro-differentiating and antimetastatic action without the toxic effects of chemotherapy.